FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2570328141> ?p ?o ?g. }

• W2570328141 abstract "Controversies were previously observed with the concomitant use of clopidogrel and Proton Pump Inhibitors (PPIs), especially omeprazole, following coronary angioplasty. Even though several studies showed no interaction between clopidogrel and PPIs, questions have been raised about the decrease in antiplatelet effects of clopidogrel with PPIs. A previously published meta-analysis showed concomitant use of clopidogrel and PPIs to be associated with higher adverse cardiovascular outcomes. However, data which were used were extracted from studies published before the year 2012. Whether these controversies still exist in this new era is not clear. Therefore, we aim to show if the concomitant use of clopidogrel and PPIs is still associated with higher adverse outcomes following Percutaneous Coronary Intervention (PCI) using data obtained from recently published studies (2012 to 2016).Electronic databases were searched for recent publications (2012-2016) comparing (clopidogrel plus PPIs) versus clopidogrel alone following PCI. Adverse cardiovascular outcomes were considered as the clinical endpoints. Odds Ratios (OR) with 95% Confidence Intervals (CI) were used as the statistical parameters and the pooled analyses were performed with RevMan 5.3 software.Eleven studies with a total number of 84,729 patients (29,235 patients from the PPIs group versus 55,494 patients from the non-PPIs group) were included. Results of this analysis showed that short term mortality and Target Vessel Revascularization (TVR) significantly favored the non-PPIs group with OR: 1.55; 95% CI: 1.43-1.68, P < 0.00001 and OR: 1.26; 95% CI: 1.06-1.49, P = 0.009 respectively. Long-term Major Adverse Cardiac Events (MACEs), Myocardial Infarction (MI), Stent Thrombosis (ST) and TVR significantly favored patients who did not use PPIs with OR: 1.37; 95% CI: 1.23-1.53, P < 0.00001, OR: 1.41; 95% CI: 1.26-1.57, P < 0.00001 and OR: 1.38; 95% CI: 1.13-1.70, P = 0.002 and OR: 1.28; 95% CI: 1.01-1.61, P = 0.04 respectively. However, the result for long term mortality was not statistically significant.The combined use of clopidogrel with PPIs is still associated with significantly higher adverse cardiovascular events such as MACEs, ST and MI following PCI supporting results of the previously published meta-analysis. However, long-term mortality is not statistically significant warranting further analysis with randomized patients." @default.
• W2570328141 created "2017-01-13" @default.
• W2570328141 creator A5009821583 @default.
• W2570328141 creator A5030630837 @default.
• W2570328141 creator A5055034171 @default.
• W2570328141 creator A5062986979 @default.
• W2570328141 date "2017-01-05" @default.
• W2570328141 modified "2023-10-01" @default.
• W2570328141 title "Is the concomitant use of clopidogrel and Proton Pump Inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty?: a systematic review and meta-analysis of recently published studies (2012 – 2016)" @default.
• W2570328141 cites W1499360650 @default.
• W2570328141 cites W1554040650 @default.
• W2570328141 cites W1797063147 @default.
• W2570328141 cites W1815519940 @default.
• W2570328141 cites W1966457982 @default.
• W2570328141 cites W1980111788 @default.
• W2570328141 cites W1989306687 @default.
• W2570328141 cites W1990333964 @default.
• W2570328141 cites W1996193478 @default.
• W2570328141 cites W1998764586 @default.
• W2570328141 cites W2011574376 @default.
• W2570328141 cites W2038485200 @default.
• W2570328141 cites W2062754756 @default.
• W2570328141 cites W2068432481 @default.
• W2570328141 cites W2073622252 @default.
• W2570328141 cites W2085492567 @default.
• W2570328141 cites W2092545425 @default.
• W2570328141 cites W2103312808 @default.
• W2570328141 cites W2105005467 @default.
• W2570328141 cites W2134833483 @default.
• W2570328141 cites W2138692723 @default.
• W2570328141 cites W2143742417 @default.
• W2570328141 cites W2143777566 @default.
• W2570328141 cites W2152376036 @default.
• W2570328141 cites W2282589332 @default.
• W2570328141 cites W2608052100 @default.
• W2570328141 cites W2883081813 @default.
• W2570328141 cites W4292547098 @default.
• W2570328141 doi "https://doi.org/10.1186/s12872-016-0453-6" @default.
• W2570328141 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5221663" @default.
• W2570328141 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28056809" @default.
• W2570328141 hasPublicationYear "2017" @default.
• W2570328141 type Work @default.
• W2570328141 sameAs 2570328141 @default.
• W2570328141 citedByCount "58" @default.
• W2570328141 countsByYear W25703281412017 @default.
• W2570328141 countsByYear W25703281412018 @default.
• W2570328141 countsByYear W25703281412019 @default.
• W2570328141 countsByYear W25703281412020 @default.
• W2570328141 countsByYear W25703281412021 @default.
• W2570328141 countsByYear W25703281412022 @default.
• W2570328141 countsByYear W25703281412023 @default.
• W2570328141 crossrefType "journal-article" @default.
• W2570328141 hasAuthorship W2570328141A5009821583 @default.
• W2570328141 hasAuthorship W2570328141A5030630837 @default.
• W2570328141 hasAuthorship W2570328141A5055034171 @default.
• W2570328141 hasAuthorship W2570328141A5062986979 @default.
• W2570328141 hasBestOaLocation W25703281411 @default.
• W2570328141 hasConcept C126322002 @default.
• W2570328141 hasConcept C156957248 @default.
• W2570328141 hasConcept C164705383 @default.
• W2570328141 hasConcept C197934379 @default.
• W2570328141 hasConcept C2777849778 @default.
• W2570328141 hasConcept C2778905298 @default.
• W2570328141 hasConcept C2779384505 @default.
• W2570328141 hasConcept C2780326628 @default.
• W2570328141 hasConcept C2780400711 @default.
• W2570328141 hasConcept C45393284 @default.
• W2570328141 hasConcept C500558357 @default.
• W2570328141 hasConcept C555175668 @default.
• W2570328141 hasConcept C71924100 @default.
• W2570328141 hasConceptScore W2570328141C126322002 @default.
• W2570328141 hasConceptScore W2570328141C156957248 @default.
• W2570328141 hasConceptScore W2570328141C164705383 @default.
• W2570328141 hasConceptScore W2570328141C197934379 @default.
• W2570328141 hasConceptScore W2570328141C2777849778 @default.
• W2570328141 hasConceptScore W2570328141C2778905298 @default.
• W2570328141 hasConceptScore W2570328141C2779384505 @default.
• W2570328141 hasConceptScore W2570328141C2780326628 @default.
• W2570328141 hasConceptScore W2570328141C2780400711 @default.
• W2570328141 hasConceptScore W2570328141C45393284 @default.
• W2570328141 hasConceptScore W2570328141C500558357 @default.
• W2570328141 hasConceptScore W2570328141C555175668 @default.
• W2570328141 hasConceptScore W2570328141C71924100 @default.
• W2570328141 hasIssue "1" @default.
• W2570328141 hasLocation W25703281411 @default.
• W2570328141 hasLocation W25703281412 @default.
• W2570328141 hasLocation W25703281413 @default.
• W2570328141 hasLocation W25703281414 @default.
• W2570328141 hasOpenAccess W2570328141 @default.
• W2570328141 hasPrimaryLocation W25703281411 @default.
• W2570328141 hasRelatedWork W2000037293 @default.
• W2570328141 hasRelatedWork W2039184886 @default.
• W2570328141 hasRelatedWork W2040481489 @default.
• W2570328141 hasRelatedWork W2042228130 @default.
• W2570328141 hasRelatedWork W2088096773 @default.
• W2570328141 hasRelatedWork W2092545425 @default.
• W2570328141 hasRelatedWork W2176938746 @default.
• W2570328141 hasRelatedWork W2519252049 @default.
• W2570328141 hasRelatedWork W4254092906 @default.
• W2570328141 hasRelatedWork W2231449278 @default.

• next